Vol 65 No 05

Cervicovaginal microbiome and HPV progression

May 21, 2020

Results from a longitudinal study suggest that bacteria in the cervicovaginal microbiome (CVM) may play a role in risk of progression of high-risk human papillomavirus (HR-HPV) to cervical precancer.

Vasomotor symptoms and faster epigenetic aging

May 21, 2020

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.

Managing BRCA results from 23andMe

May 15, 2020

During a routine office visit, a patient mentions that she recently submitted a saliva sample to 23andMe. The company performed BRCA analysis and the patient wants to discuss the results with you. How should you approach the discussion?

Vulvovaginal atrophy among breast cancer survivors

May 13, 2020

A diagnosis of vulvovaginal atrophy (VVA) in breast cancer survivors is associated with a significant increase in the burden of illness and social costs, according to an Italian Delphi Panel in the journal Supportive Care in Cancer. These findings are primarily due to a rise in comorbidities and resource utilization, but adequate treatment might reduce the impact of the condition.

ACOG Guidelines at a Glance: Heavy Menstrual Bleeding in Adolescents

May 12, 2020

In this piece, read ACOG’s Committee Opinion #785 on Screening and Management of Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding, with expert commentary from Contemporary OB/GYN Board Member Dr. Paula J. Hillard.